Startup Aerium Therapeutics Developing Antibody Treatment for Covid-19 – The Wall Street Journal

Venture-capital firm Omega Funds has created and provided initial funding to Aerium Therapeutics, a biotech startup seeking to develop a broadly effective drug for Covid-19.

Aerium, based in Boston and Lausanne, Switzerland, said it is developing a two-antibody combination treatment. In preclinical studies, the antibodies have been potent neutralizers of SARS-CoV-2 and its variants. That group includes Omicron and its sub-variants, among them the BA.2 strain that has been detected in at least 40 countries. The Centers for...

Follow this link:

Startup Aerium Therapeutics Developing Antibody Treatment for Covid-19 - The Wall Street Journal

Related Posts
Tags: